PCSK9 and neoplasm: Based on the neoplasm risk reducing effects and specific mechanisms of PCSK9 that influence neoplasms’ occurrence and progression from the study’s results and preceding evidence, further agents conforming to similar mechanisms with more specific and concentrated anti-tumor effects are expected to be developed.